Plasma cell characteristics predict benefit from intensified therapy in AL amyloidosis

被引：0

作者：

Steinhardt, Maximilian ^{[1
,2
,3
]}

Oubari, Sara ^{[4
]}

Cejka, Vladimir ^{[1
]}

Morbach, Caroline ^{[5
]}

Papagianni, Aikaterini ^{[5
]}

Sommer, Claudia ^{[5
]}

Stoerk, Stefan ^{[5
]}

Einsele, Hermann ^{[5
]}

Carpinteiro, Alexander ^{[4
]}

Kortuem, Martin ^{[5
]}

机构：

[1] Julius Maximilians Univ Wurzburg, Wurzburg, Germany

[2] Univ Hosp Wurzburg, Interdisciplinary Amyloidosis Ctr Northern Bavari, Wurzburg, Germany

[3] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany

[4] Univ Duisburg Essen, Essen, Germany

[5] Univ Hosp Wurzburg, Wurzburg, Germany

来源：

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2024年 / 31卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

235

引用

页码：S94 / S95

页数：2

共 50 条

[31] Multiple endocrine neoplasms in a patient with AL amyloidosis-associated plasma cell dyscrasia
Seki, K
Wakatsuki, S
Hizawa, K
Hasegawa, T
Fujinaka, Y
Yokogoshi, H
Saito, S
Sano, T
ENDOCRINE PATHOLOGY, 1997, 8 (02) : 153 - 160
[32] High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review
Varga, Cindy
Comenzo, Raymond L.
BONE MARROW TRANSPLANTATION, 2019, 54 (04) : 508 - 518
[33] High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review
Cindy Varga
Raymond L. Comenzo
Bone Marrow Transplantation, 2019, 54 : 508 - 518
[34] Who should benefit from diabetes cell therapy?
Vantyghem, M. C.
Balavoine, A. S.
Kerr-Conte, J.
Pattou, F.
Noel, C.
ANNALES D ENDOCRINOLOGIE, 2009, 70 (06) : 443 - 448
[35] ADVANCED THERAPY FOR AL AMYLOIDOSIS - IV MELPHALAN WITH BLOOD STEM-CELL RESCUE
COMENZO, RL
SIMMS, RW
VOSBURGH, E
SKINNER, M
ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1494 - 1494
[36] Treatment-Emergent Effects May Predict Benefit From Endocrine Therapy
Henry, N. Lynn
Stearns, Vered
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18) : 2233 - 2235
[37] Reply: How well can frailty predict no benefit from ICD therapy?
Gotzmann, Michael
Lewenhardt, Marie
Kreimer, Fabienne
CLINICAL CARDIOLOGY, 2024, 47 (02)
[38] FACTORS THAT PREDICT WHICH PRETERM INFANTS BENEFIT MOST FROM MASSAGE THERAPY
SCAFIDI, FA
FIELD, T
SCHANBERG, SM
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 1993, 14 (03): : 176 - 180
[39] Imaging may predict whether drag addicts can benefit from therapy
Anon
Biophotonics International, 2001, 8 (05):
[40] Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma
Sonpavde, Guru
Pond, Gregory R.
Fougeray, Ronan
Bellmunt, Joaquim
BJU INTERNATIONAL, 2015, 115 (06) : 854 - 855

← 1 2 3 4 5 →